Search for: "Adams v. Collier" Results 1 - 19 of 19
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 May 2019, 2:18 pm by Jonathan H. Adler
Collier, and Justice Thomas's opinion concurring in the denial of certiorari in Price v. [read post]
23 Jun 2023, 9:30 pm by Karen Tani
  Word from George Burton Adams, via Samuel Bray, Notre Dame Law (Volokh Conspiracy). [read post]
24 Dec 2008, 12:01 pm
Dec. 19, 2008)Absence of 50(b) motion in the trial court deprives Appeals Court of ability to consider AT&T's appeal from J* for EEOC on its religion (Jehovah's Witnesses)/failure-to-accommodate, discharge discrim suitDC Circuit* Adams v. [read post]
27 May 2007, 10:11 pm
Peter Collier writes: “Memorial Day ain't what it used to be. [read post]
4 Nov 2023, 9:09 pm by Ilana Korchia
Hepatitis A outbreaks associated with fresh, frozen, and minimally processed produce, worldwide, from 1983 to 2016—adapted and expanded from Sivapalasingam et al., 2004 and Fiore, 2004. [read post]
16 Oct 2022, 6:51 pm by Bill Marler
As of May 31, 2022, a total of 18 outbreak-associated cases of hepatitis A have been reported from 3 states – California (16), Minnesota (1), and North Dakota (1). [read post]
17 Feb 2017, 1:34 pm by Bill Marler
Beginning in September 2016, several states, CDC, and the FDA investigated a multistate outbreak of foodborne hepatitis A. [read post]
7 Apr 2010, 3:44 pm by admin
The following is a summary review of articles from all over the nation concerning environmental law settlements, decisions, regulatory actions and lawsuits filed during the past week. [read post]
7 Oct 2022, 4:09 am by Bill Marler
Officials in New Zealand investigating Hepatitis A cases linked to berries have identified a connection with a past outbreak in Europe. [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]